Genocea Biosciences, Inc. Commences Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Genocea Biosciences (GNCA) Falls on Plans to Offer Common Stock
July 29, 2015 5:53 PM EDTGenocea Biosciences (NASDAQ: GNCA) is trading down 8% after-hours after the company announced that it intends to offer and sell shares of its common stock in an underwritten public offering. As part of this proposed offering, Genocea intends to grant the underwriters a 30-day... More



